Answers are grounded in this paper and cite their sources.
Retrospective analysis reveals vaccination and immunoglobulin efficacy in preventing measles in children, suggesting improvements are needed.
Measles is one of the most highly contagious airborne infections. Those who are not vaccinated or have not been ill after contact become ill in almost 100% of cases. Objective: to evaluate the effectiveness of emergency measles prevention in children in a specialized institution with round-the-clock stay. Materials and methods: a retrospective analysis of a measles outbreak in a specialized psychoneurological children's home was conducted. Results: the zero patient was an unvaccinated girl aged 1 year 26 days, who had previously been treated in a hospital for COVID-19, where at the same time measles patients were being treated. She fell ill after 14 days, was re-hospitalized on the 17th day. On the same day, 171 contacts were identified, 7/5.3% of employees were revaccinated with a live measles monovalent vaccine, 10/41.7% of children over 12 months of age received a combined vaccine against measles, rubella and mumps and 14/58.3% of children under 12 months of age received normal human immunoglobulin was administered intramuscularly in 1 dose (1.5 ml). During the period of epidemiological observation, 8/33.3% of children who received emergency prophylaxis fell ill (1/10.0% — trivaccine and 7/50.0% — immunoglobulin). All suffered from typical measles of moderate severity. Conclusion. The development of the disease in 50.0% of cases with consistent involvement in the epidemic process after passive prophylaxis indicates insufficient effectiveness of the administration of the minimum recommended dose of immunoglobulin.
No takes yet. Share an insight, caveat, or question.
Chernova et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: